Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions

JACC: Cardiovascular Interventions

Volumn 5, Issue 6, 2012, Pages 666-674

  Yazdani, Saami K ^a   Farb, Andrew ^b   Nakano, Masataka ^a   Vorpahl, Marc ^a   Ladich, Elena ^a   Finn, Aloke V ^c   Kolodgie, Frank D ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bare metal stent(s); drug eluting stent(s); pathology; saphenous vein bypass graft

Indexed keywords

FORMALDEHYDE; FIXATIVE; METAL;

AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY THROMBOSIS; DRUG ELUTING STENT; FEMALE; FIBRIN DEPOSITION; GRAFT NECROSIS; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MORBIDITY; MORPHOLOGY; MORPHOMETRICS; MORTALITY; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; SAPHENOUS VEIN GRAFT; STENT THROMBOSIS; VEIN THROMBOSIS; AUTOPSY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; GRAFT OCCLUSION; INSTRUMENTATION; MIDDLE AGED; NECROSIS; PATHOLOGY; PROSTHESIS; REGISTER; RISK ASSESSMENT; RISK FACTOR; SAPHENOUS VEIN; STENT; TIME; TISSUE FIXATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ATHEROSCLEROSIS; AUTOPSY; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FIXATIVES; FORMALDEHYDE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; METALS; MIDDLE AGED; NECROSIS; NEOINTIMA; PLAQUE, ATHEROSCLEROTIC; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SAPHENOUS VEIN; STENTS; TIME FACTORS; TISSUE FIXATION; TREATMENT OUTCOME;

EID: 84862882427     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.12.017     Document Type: Article

References (36)

1. Hamby RI, Aintablian A, Handler M, et al. Aortocoronary saphenous vein bypass grafts. Long-term patency, morphology and blood flow in patients with patent grafts early after surgery. Circulation 1979;60: 901-9. (Pubitemid 10239348)
2. Virmani R, Atkinson JB, Forman MB. Aortocoronary saphenous vein bypass grafts. Cardiovasc Clin 1988;18:41-62.
3. Laird-Meeter K, van Domburg R, van den Brand MJ, Lubsen J, Bos E, Hugenholtz PG. Incidence, risk, and outcome of reintervention after aortocoronary bypass surgery. Br Heart J 1987;57:427-35. (Pubitemid 17069268)
4. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26. (Pubitemid 26288642)
5. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001;38:150-4. (Pubitemid 32613842)
6. de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993;21:1539-49. (Pubitemid 23170424)
7. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-95. (Pubitemid 24256751)
8. Brener SJ, Ellis SG, Apperson-Hansen C, Leon MB, Topol EJ. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol 1997;79:13-8. (Pubitemid 127673668)
9. Savage MP, Douglas JS Jr., Fischman DL, et al., for the Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-7. (Pubitemid 27417973)
10. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. (Pubitemid 37186209)
11. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. (Pubitemid 38067635)
12. Chu WW, Rha SW, Kuchulakanti PK, et al. Efficacy of sirolimuseluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006;97:34-7. (Pubitemid 41828119)
13. Brilakis ES, Saeed B, Banerjee S. Use of drug-eluting stents in saphenous vein aortocoronary bypass graft lesions: a critical appraisal. J Interv Cardiol 2008;21:151-7. (Pubitemid 351492481)
14. Vermeersch P, Agostoni P, Verheye S, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 2006;48:2423-31. (Pubitemid 44895571)
15. Vermeersch P, Agostoni P, Verheye S, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 2007;50:261-7. (Pubitemid 47039289)
16. Goswami NJ, Gaffigan M, Berrio G, et al. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent registry. Catheter Cardiovasc Interv 2010;75:93-100.
17. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
18. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002;105:2974-80. (Pubitemid 34693829)
19. Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart 2004;90:1385-91. (Pubitemid 39626306)
20. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
21. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41. (Pubitemid 46717966)
22. Nakazawa G, Finn AV, Joner M, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008;118:1138-45.
23. Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-22.
24. Nakazawa G, Finn AV, Vorpahl M, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol 2009;54:1924-31.
25. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97: 916-31. (Pubitemid 28113931)
26. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153:1301-10. (Pubitemid 28465854)
27. Meyerson SL, Skelly CL, Curi MA, et al. The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graft. J Vasc Surg 2001;34:90-7. (Pubitemid 33660695)
28. Butany JW, David TE, Ojha M. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses. Can J Cardiol 1998;14:671-7. (Pubitemid 28276706)
29. Peykar S, Angiolillo DJ, Bass TA, Costa MA. Saphenous vein graft disease. Minerva Cardioangiol 2004;52:379-90. (Pubitemid 39457519)
30. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10. (Pubitemid 46986103)
31. Depre C, Havaux X, Wijns W. Pathology of restenosis in saphenous bypass grafts after long-term stent implantation. Am J Clin Pathol 1998;110:378-84.
32. van Beusekom HM, van der Giessen WJ, van Suylen R, Bos E, Bosman FT, Serruys PW. Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 1993;21:45-54.
33. Lee MS, Yang T, Kandzari DE, Tobis JM, Liao H, Mahmud E. Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention. Am J Cardiol 2010;105: 1076-82.
34. Gioia G, Benassi A, Mohendra R, Chowdhury K, Masood I, Matthai W. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Catheter Cardiovasc Interv 2008;72:13-20. (Pubitemid 352008974)
35. Park KW, Kim CH, Lee HY, et al. Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents. Am Heart J 2010;159:446-53.e3.
36. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57:390-8.